New Products

ALISO VIEJO, Calif. — A search feature that allows pharmacies to quickly determine why patients are calling so they can better serve their needs and a patient registration system that allows easier enrollment in medication-time reminders, disease management and smoking-cessation programs are among the new features of the latest version of PrescribeWellness' software system.

NORTH WALES, Pa. — Teva Pharmaceutical Industries has launched a generic inhaler used to treat bronchospasm, the company said.

Teva announced the introduction of levalbuterol inhalation solution. The product is a generic version of Sunovion's Xopenex and is available in the 0.31 mg, 0.63 mg and 1.25 mg strengths.

Various versions of the drug had sales of $438.8 million in 2012, according to IMS Health.

SPOKANE, Wash. — Zak Designs has announced a new GoPak container designed to make packing lunches easy and without the worry of messy spills.

NEW YORK — Syneron Beauty has announced the launch of the Pearl Brilliant White Ionic Teeth Whitening system, which according to the manufacturer, features its patented ionic technology — the first new at-home teeth whitening technology to be cleared by the FDA in more than a decade.

In a clinical study, the system was shown to provide maximum whitening results of up to 10 shades after 50 minutes of treatment with virtually no sensitivity, the company stated.

NEW YORK — Planters Peanuts has launched a new snack mix with the aim to provide a sustaining boost of energy.

New Planters NUT-rition Sustaining Energy Mix is designed to provide wholesome fuel and is a good source of protein, fiber and four vitamins and minerals, according to the company.

Planters NUT-rition is available in three varieties:

HYDERABAD — The Food and Drug Administration has approved two generic drugs made by Aurobindo Pharma, the drug maker said.

The company announced Tuesday the approval of quinapril tablets in the 5-mg, 10-mg, 20-mg and 40-mg strengths. The drug is a generic version of Pfizer's Accupril and is used to treat high blood pressure. Various versions of the drug had sales of about $49 million during the 12-month period ending in September, according to IMS Health.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug that reverses the effects of anticoagulant drugs in patients who have suffered acute major bleeding, the agency said.

The FDA announced the approval of CSL Behring's Kcentra (prothrombin complex concentrate [human]) for the urgent reversal of vitamin K antagonist, or VKA drugs such as warfarin.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment for a genetic disorder that affects about 500 people in the United States and 3,000 worldwide, the agency said Tuesday.